Skip to content

Coronavirus (COVID-19) vaccines, %%COUNTRY%% data

COVID-19 vaccination, %%COUNTRY%% data


Source: World Health Organization

COVID-19 vaccine coverage, %%COUNTRY%%


Source: World Health Organization

Why are some reported vaccination coverage statistics higher than 100% of population?

Changes in population due to migration, birth or death may not be accurately reflected in latest population estimates. If a country has seen increasing migration trends or if a national population statistic is lower than the count recorded in statistical calculations, it can result in a vaccination coverage percentage greater than 100%.

Metadata

Glossary and definitions

Total doses administered

Number of doses administered in a country, area, or territory, regardless of if they have been administered as part of a primary series or as booster/additional doses.

Vaccinated with at least one COVID-19 vaccine doseHaving received a minimum of one dose of a COVID-19 vaccine.
This includes both (i) those individuals who have received only one dose, as well as (ii) those who have a first dose and subsequent ones.
Vaccinated with a complete COVID-19 primary vaccine seriesHaving received the number of doses of a COVID-19 vaccine corresponding to that product's primary series, as per its product-specific use authorization in the country where it was administered.
The number of doses constituting a primary series varies by product and by country. For most vaccine products in most countries, a complete primarty series consists of two doses.
Vaccinated with at least one COVID-19 vaccine booster doseHaving received a minimum of one booster or additional dose of a COVID-19 vaccine, following the completion of a primary series.
This includes both (i) those individuals who have only received one booster/additional dose, as well as (ii) those who have a first booster / additional dose and subsequent ones.
A booster dose is a dose recommended in addition to a primary series. An additional dose is a dose administered as part of an extended primary series, e.g. when the number of doses constituting a primary series for a product is increased during the vaccine rollout.

Data sources

COVID-19 vaccination data

COVID-19 vaccination data are collected via WHO regional office-specific systems for monitoring COVID-19 vaccination uptake. These data are pooled from numerous sources, including direct reports from Member States, WHO review of publicly available official data, or data collected and published by third-party sites. Data published by third-party sites have not been validated by WHO, and WHO cannot comment on accuracy or completeness. Differences in counts may occur compared to other sources, due to different inclusion criteria and data cut-off times.

Population data

Estimated populations and projections are drawn from:

*Total population for France has been adjusted to account for the following overseas territories (French Guiana, Guadeloupe, Martinique, Mayotte, Réunion, Saint Martin).

Notes

Vaccine product introduction

Where multiple vaccines are used in a country, are, or territory, the start date displayed is equivalent to start date of the first vaccine product introduced. Suspensions (temporary or otherwise) of vaccination rollout are not taken into consideration.

Disclaimer regarding endorsement

The information contained in this dashboard does not in any way imply endorsement, certification, warranty of fitness, or recommendation by WHO of any company or of any vaccine or other product for any purpose and does not imply preference over vaccines or other products of a similar nature that are not mentioned. WHO furthermore does not warrant that the vaccines or other products listed are of acceptable quality, have obtained regulatory approval in any country, or that their use is otherwise in accordance with the national laws and regulations of any country, including but not limited to patent laws. The inclusion of vaccines or other products in these analyses and underlying datasets does not imply any approval by WHO of the vaccines or other products in question (which is the sole prerogative of national authorities).

Copyright and licensing

Copyright

Attribution 4.0 International (CC BY 4.0)

License

The World Health Organization (“WHO”) encourages public access and use of the data that it collects and publishes on its web site data.who.int. The data are organized in datasets and made available in machine-readable format (“Datasets”). The Datasets have been compiled from data provided by WHO’s Member States under the WHO policy on the use and sharing of data collected by WHO in Member States outside the context of public health emergencies.

Use of the data derived from the Datasets, which may appear in formats such as tables and charts, is also subject to these Terms and Conditions. Datasets may include data describing the Dataset called “Metadata”. If any datasets are credited to a source other than WHO, then those materials are not covered by these Terms and Conditions, and permission should be sought from the source provided. You are responsible for determining if this is the case, and if so, you are responsible for obtaining any necessary permission from the sources indicated. The risk of claims resulting from infringement of any third-party-owned component in the materials rests solely with you.

You may use our application programming interfaces (“APIs”) to facilitate access to the Datasets, whether through a separate web site or through another type of software application. By using the Datasets or any presentations of data derived from them, or by using our APIs in connection with the Datasets, you agree to be bound by these Terms and Conditions, as may be amended from time to time by WHO at its sole discretion.

Unless specifically indicated otherwise, these Datasets are provided to you under a Creative Commons Attribution 4.0 International License (CC BY 4.0), with the additional terms below. The basic terms applicable to the CC BY 4.0 license may be accessed here. By downloading or using the Datasets, you agree to comply with the terms of the CC BY 4.0 license, as well as the following mandatory and binding addition:

Any dispute relating to the interpretation or application of this license shall, unless amicably settled, be subject to conciliation. In the event of failure of the latter, the dispute shall be settled by arbitration. The arbitration shall be conducted in accordance with the modalities to be agreed upon by the parties or, in the absence of agreement, with the UNCITRAL Arbitration Rules. The parties shall accept the arbitral award as final.

Permission typePublicly accessible
Prohibited uses

You shall not attempt to de-anonymise the Datasets or use the Datasets in a manner that falsifies or misrepresents their content.

You shall not, in connection with your use of the Datasets published on data.who.int, state or imply that WHO endorses, or is affiliated with, you, or that WHO endorses your use of data.who.int, or any content, output, or analysis resulting from or related to the data.who.int, or any entity, organization, company, product or services.

Citation

World Health Organization 2023 data.who.int, WHO Coronavirus (COVID-19) dashboard > Vaccines [Dashboard]. https://data.who.int/dashboards/covid19/vaccines

Disclaimer

WHO reserves the right at any time and from time to time to modify or discontinue, temporarily or permanently, the Datasets, or any means of accessing or utilizing the Datasets with or without prior notice to you.

Maps
The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.

All references to Kosovo should be understood to be in the context of the United Nations Security Council resolution 1244 (1999).

A dispute exists between the Governments of Argentina and the United Kingdom of Great Britain and Northern Ireland concerning sovereignty over the Falkland Islands (Malvinas).

The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

All reasonable precautions have been taken by WHO to verify the accuracy of the Datasets. However, the Datasets are being provided without warranty of any kind, either expressed or implied. You will be solely responsible for your use of the Datasets. In no event shall WHO be liable for any damages arising from such use.

For full disclaimers, terms of use and your indemnification of WHO, please visit Terms and Conditions.